REQUEST A DEMO
Total
USD $0.00
Search more companies

Bristol-Myers Squibb Kft. (Hungary)

Main Activities: Other Management Consulting Services
Full name: Bristol-Myers Squibb Kft. Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

The fifth largest American drug company, Bristol-Myers Squibb is represented in Hungary since the autumn of 1993. In 1996, the company acquired 99 percent ownership in the Hungarian Pharmavit Inc. Pharmavit traded with the products of the parent company, such as drugs for cancer, cardiovascular diseases HIV, and the marketing of antibiotics.

Headquarters
Csorsz utca 49-51. foldszint
Budapest; Budapest; Postal Code: 1124

Contact Details: Purchase the Bristol-Myers Squibb Kft. report to view the information.

Website: http://www.bms.hu

Basic Information
Total Employees:
Purchase the Bristol-Myers Squibb Kft. report to view the information.
Outstanding Shares:
Purchase the Bristol-Myers Squibb Kft. report to view the information.
Registered Capital:
Purchase the Bristol-Myers Squibb Kft. report to view the information.
Financial Auditors:
Purchase the Bristol-Myers Squibb Kft. report to view the information.
Incorporation Date:
May 04, 2001
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
99.9%
Company Performance
Financial values in the chart are available after Bristol-Myers Squibb Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
33.4%
Total operating revenue
33.44%
Operating profit (EBIT)
38.92%
EBITDA
28%
Net Profit (Loss) for the Period
40.2%
Total assets
21.96%
Total equity
22.97%
Operating Profit Margin (ROS)
0.28%
Net Profit Margin
0.48%
Return on Equity (ROE)
2.3%
Quick Ratio
0.11%
Cash Ratio
-0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?